Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP)

The plastic that softens food packaging, medical tubing, and vinyl flooring does not stay put. A chemical called DEHP steadily migrates into food, dust, and air, and your body absorbs it and breaks it down within hours.

This test measures one of those breakdown products in your urine, giving you a direct read on how much of this plastics chemical is currently reaching your body. It is a window into an exposure that routine blood work never looks for.

What This Marker Actually Measures

MEHHP (mono-(2-ethyl-5-hydroxyhexyl) phthalate) is not a chemical you are directly exposed to. It is what your body makes after it takes in di(2-ethylhexyl) phthalate, usually shortened to DEHP, the most common plasticizer used to make plastics flexible. Your gut first turns DEHP into a molecule called MEHP, then your body oxidizes that into MEHHP and a handful of related products before flushing them out in urine.

MEHHP is one of the more useful of these markers because it shows up in urine at levels roughly ten times higher than MEHP, so it is easier to detect reliably. A high result means your recent DEHP exposure was higher. A low result usually means less recent exposure, faster clearance, or more diluted urine.

This is a research and exploratory marker, not an established clinical test. There are no standardized cutpoints that define a "normal" or "dangerous" level, and a single reading does not diagnose any disease. Its value is in showing your exposure and letting you track whether changes you make actually lower it. That is exactly why getting a baseline now and watching your own trend gives you a head start as the science matures.

Thyroid Hormone Disruption

The most consistent human signal for this family of chemicals is a modest effect on the thyroid. A pooled analysis of 13 human studies found that higher urinary MEHHP tracked with slightly lower total thyroxine (total T4, your main circulating thyroid hormone), with a very weak but statistically real link (a pooled correlation of -0.03, where 0 would mean no relationship at all).

A separate study of Chinese adolescents pointed the same way, finding that urinary DEHP metabolites including MEHHP were generally associated with lower total T4 in blood. The effect on any one person is small, and these are observational findings rather than proof that the chemical is driving thyroid changes. If you have thyroid symptoms or abnormal thyroid labs, this marker is context, not an explanation on its own.

Insulin Resistance and Type 2 Diabetes

Several studies connect higher DEHP exposure to problems with blood sugar control. In a panel of older adults, the combined level of MEHHP and a closely related metabolite was associated with higher insulin resistance, and the link was stronger in people with a history of diabetes and in women. Markers of oxidative stress (chemical wear-and-tear inside cells) appeared to be part of the pathway.

A 2024 case-control study found that higher urinary MEHHP was associated with type 2 diabetes, with a dose-response that was not a straight line, and a DNA-damage marker explained a small share of the association. In an elderly Chinese cohort, MEHHP was one of the stronger diabetes predictors, with roughly twice the odds comparing higher to lower exposure. These are associations, not proof that lowering the chemical prevents diabetes.

Obesity and Blood Fats

In a study of more than a thousand Spanish men, those with higher urinary MEHHP had about 26% higher odds of general obesity (odds ratio 1.26). In a large sample of US adults, people in the highest quarter of MEHHP had lower HDL cholesterol, the protective kind, and higher triglycerides than those in the lowest quarter.

Higher DEHP metabolites including MEHHP have also been linked to metabolic dysfunction-associated fatty liver disease (a condition where fat builds up in the liver alongside metabolic problems). Because body fat itself can track with exposure, these associations should be read as part of a broader metabolic picture rather than a single cause and effect.

Fertility and Pregnancy

Reproductive findings are among the more concerning, though still observational. In women of reproductive age, each doubling of urinary MEHHP was associated with slightly lower anti-Mullerian hormone, a measure of ovarian egg reserve. In women undergoing IVF, higher DEHP metabolites in the fluid around the egg were tied to fewer eggs retrieved and fewer mature eggs.

In a pregnancy study, women in the highest quarter of first-trimester MEHHP had about twice the odds of miscarriage (odds ratio 2.12) compared with the lowest, with a steadily rising dose-response. In men, higher urinary MEHHP has been associated with greater odds of adult-onset low testosterone. For anyone trying to conceive or already pregnant, this marker can flag an exposure worth reducing.

Physical Function and the Nervous System

In a cohort of Korean adults aged 60 to 98 followed over time, each doubling of urinary MEHHP was linked to about 15% higher odds of slow walking speed (odds ratio 1.15), and people in the highest quarter had roughly 47% higher odds than those in the lowest. Walking speed is a well-established marker of aging and physical decline.

In US adults, higher urinary MEHHP was associated with higher blood levels of neurofilament light chain, a protein released when nerve fibers are damaged. The authors were explicit that the meaning and cause of this link are still uncertain and that more research is needed before drawing clinical conclusions.

Making Sense of Mixed Findings

The evidence is not uniform, and that is worth understanding rather than glossing over. For cardiovascular death, one analysis of adults with diabetes found higher MEHHP linked to more than double the risk (hazard ratio 2.17), while a broader analysis of general adults found no significant link. This is not a contradiction so much as a reflection of what the marker is: an exposure measure, not a fixed "good number" or "bad number." Whether an exposure translates into harm depends on the dose, the person, the timing, and the outcome being studied. Different populations and different adjustments produce different signals, which is exactly why individual readings should be interpreted cautiously and tracked over time rather than treated as a verdict.

Why One Reading Is Not Enough

DEHP clears from the body fast, with a half-life under 24 hours, so a single urine sample mostly reflects what you were exposed to in the past day, not your typical long-term exposure. Levels also swing based on recent meals and how much water you drank. Studies tracking people day to day found substantial variation within the same person, and a single spot sample can overestimate a longer-term average, usually by less than twofold.

This makes trend more meaningful than any one number. A practical approach is to get a baseline, then retest after you change habits (for example, cutting back on packaged food or certain personal care products) to see whether your exposure actually dropped. Because the chemical clears within a day, a real reduction in exposure shows up in urine quickly. Repeating the test two or three times, ideally using first-morning samples, gives a far more trustworthy picture than a lone reading.

When Results Can Be Misleading

A few factors can distort a single reading and should temper how much weight you put on it.

• Urine dilution: how much water you drank changes the raw concentration, which is why labs often adjust for creatinine or specific gravity. An uncorrected value can look high or low simply because of hydration.
• Timing and recent meals: because the chemical clears within a day, a value largely reflects the last several hours. A single packaged meal shortly before collection can push the number up temporarily.
• Kidney function: MEHHP is cleared by the kidneys, so altered kidney function can shift how much appears in urine independent of your actual intake.
• Inherited metabolism: common gene variants near CYP2C9 and a urinary transport gene explain part of why two people with the same exposure can excrete different amounts, so levels are not a perfect one-to-one measure of intake.

What an Unexpected Result Should Prompt

This marker rarely stands alone. If your level is unexpectedly high, the most useful next step is to confirm it is not a one-off by retesting on a first-morning sample after a few days of ordinary routine, then again after you deliberately reduce likely sources. Reading it alongside companion phthalate markers such as MEOHP, MEHP, and MECPP, and their combined total, gives a fuller sense of your DEHP exposure than any single metabolite.

If persistently elevated exposure coincides with a specific concern, the sensible move is to pair it with the relevant outcome test rather than acting on exposure alone: thyroid hormones if you have thyroid symptoms, fasting glucose and insulin measures if you have metabolic risk, or ovarian reserve testing if you are planning pregnancy. An occupational or environmental medicine clinician can help interpret a high result if you have a workplace exposure, such as plastics or PVC manufacturing, where inhaled DEHP can add substantially to body burden.